678 Results

People

  1. Sklar
    Sklar
  2. Cheung
    Cheung
  3. Friedman
    Friedman
  4. Walsh
    Walsh
  5. Cheung
    Cheung
  6. Offit
    Offit
  7. Oeffinger
    Oeffinger
  8. Mandelker
    Mandelker
  9. Robson
    Robson
  10. Stadler
    Stadler

Groups

  1. General Oncology Service (678)
  2. Pediatrics, Department of (678)
  3. Population Sciences Research Program (544)
  4. Survivorship Research (495)
  5. Tow Center for Developmental Oncology (TCDO) (272)
  6. GSK Faculty (246)
  7. Department of Medicine (219)
  8. Solid Tumor Oncology Division (180)
  9. Clinical Genetics Service (158)
  10. Epidemiology and Biostatistics (131)
  1. "General Oncology Service"
Formats
  1. Journal Article (431)
  2. Meeting Abstract (205)
  3. Review (16)
  4. Book Section (10)
  5. Editorial (5)
  6. Guidelines (5)
  7. Research Letter (3)
  8. Conference Paper (2)
  9. Correspondence (1)
Groups
  1. General Oncology Service (678)
  2. Pediatrics, Department of (678)
  3. Population Sciences Research Program (544)
  4. Survivorship Research (495)
  5. Tow Center for Developmental Oncology (TCDO) (272)
  6. GSK Faculty (246)

More Groups

People
  1. Charles Sklar (322)
  2. Michael Walsh (156)
  3. Nai-Kong Cheung (111)
  4. Danielle Friedman (110)
  5. Irene Cheung (96)
  6. Kenneth Offit (83)

More People

Years
  1. 2025 (12)
  2. 2024 (25)
  3. 2023 (30)
  4. 2022 (33)
  5. 2021 (40)
  6. 2020 (40)

More Years

Publications
  1. Journal of Clinical Oncology (137)
  2. Pediatric Blood and Cancer (66)
  3. Cancer (38)
  4. Clinical Cancer Research (26)
  5. Cancer Research (22)
  6. Blood (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (152)
  2. Wiley Periodicals, Inc (68)
  3. American Association for Cancer Research (65)
  4. Oxford University Press (47)
  5. Wiley Blackwell (44)
  6. Elsevier Inc. (39)

More Publishers

Results (678)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Biochemical measures of ovarian function in female survivors of retinoblastoma treated with intra-arterial melphalan: An initial report
    Journal Article

    Marathe, P. H.; Dunkel, I. J.; Francis, J. H.; Antal, Z.; Gobin, Y. P.; Abramson, D. H.; Friedman, D. N.
    Ophthalmic Genetics (2022)

    Fulltext@MSK | Save
  • Validation of a germline genetic testing panel for hematologic malignancies using nail specimens
    Meeting Abstract

    Ceyhan-Birsoy, O.; Rana, S.; Rai, V.; Li, Y.; Yang, C.; Yelskaya, Z.; Rijo, I.; Casanova, J.; Somar, J.; Salazar, P.; more...
    Journal of Molecular Diagnostics (2022)

    Fulltext@MSK | Save
  • Inherited germline cancer susceptibility gene variants in individuals with non-muscle-invasive bladder cancer
    Journal Article

    Pietzak, E. J.; Whiting, K.; Srinivasan, P.; Bandlamudi, C.; Khurram, A.; Joseph, V.; Walasek, A.; Bochner, E.; Clinton, T.; Almassi, N.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Plasma cell-free DNA analysis uncovered tumor heterogeneity and clonal evolution during treatment for relapsed neuroblastoma
    Meeting Abstract

    Cardenas, F. I.; Kothari, P.; Tsui, D.; Basu, E.; Roberts, S.; Cheung, N. K.; Kushner, B.; Modak, S.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Reducing empiric antibiotic administration in pediatric oncology patients with non-neutropenic fever: A single center quality improvement initiative
    Meeting Abstract

    Satty, A.; Stiefel, J.; Bernot, M. R.; Hudda, Z.; Llaurador, G.; Lakkaraja, M.; Mauguen, A.; Seo, S.; Glade-Bender, J.; Sulis, M. L.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Novel infusion strategy to reduce major side effects caused by anti-GD2 monoclonal antibody naxitamab without affecting its pharmacokinetics
    Meeting Abstract

    Mora, J.; Varo, A.; Castañeda, A.; Chamorro, S.; Muñoz, J. P.; Gorostegui, M.; Celma, M. S.; Lopez, S.; Simao, M.; Perez-Jaume, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants
    Journal Article

    Liu, Y. L.; Maio, A.; Kemel, Y.; Salo-Mullen, E. E.; Sheehan, M.; Tejada, P. R.; Trottier, M.; Arnold, A. G.; Fleischut, M. H.; Latham, A.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Ethics consultation requests after implementation of an electronic health record order
    Journal Article

    Marathe, P. H.; Zhang, H.; Blackler, L.; Stetson, P. D.; Voigt, L. P.; Friedman, D. N.
    JCO Oncology Practice (2022)

    Fulltext@MSK | Save
  • Impaired proteolysis of noncanonical RAS proteins drives clonal hematopoietic transformation
    Journal Article

    Chen, S.; Vedula, R. S.; Cuevas-Navarro, A.; Lu, B.; Hogg, S. J.; Wang, E.; Benbarche, S.; Knorr, K.; Kim, W. J.; Stanley, R. F.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Phase 2 study of veliparib and local irradiation, followed by maintenance veliparib and temozolomide, in patients with newly diagnosed highgrade glioma without H3 K27M or BRAF Mutations: A report from the Children's Oncology Group ACNS1721 study
    Meeting Abstract

    Karajannis, M.; Onar-Thomas, A.; Baxter, P.; Butingan, N.; Fuller, C.; Gajjar, A.; Haque, S.; Jabado, N.; Lin, T.; Lucas, J.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save